Ayoub Nabieh, Rajendra Eeson, Su Xinyi, Jeyasekharan Anand D, Mahen Robert, Venkitaraman Ashok R
Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 2XZ, UK.
Curr Biol. 2009 Jul 14;19(13):1075-85. doi: 10.1016/j.cub.2009.05.057. Epub 2009 Jun 18.
The Rad51 recombinase assembles on DNA to execute homologous DNA recombination (HR). This process is essential to repair replication-associated genomic lesions before cells enter mitosis, but how it is started and stopped during the cell cycle remains poorly understood. Rad51 assembly is regulated by the breast cancer suppressor Brca2, via its evolutionarily conserved BRC repeats, and a distinct carboxy (C)-terminal motif whose biological function is uncertain. Using "hit-and-run" gene targeting to insert single-codon substitutions into the avian Brca2 locus, we report here a previously unrecognized role for the C-terminal motif.
We show that the avian C-terminal motif is functionally cognate with its human counterpart and identify point mutations that either abolish or enhance Rad51 binding. When these mutations are introduced into Brca2, we find that they affect neither the assembly of Rad51 into nuclear foci on damaged DNA nor DNA repair by HR. Instead, foci disassemble more rapidly in a point mutant that fails to bind Rad51, associated with faster mitotic entry. Conversely, the slower disassembly of foci in a point mutant that constitutively binds Rad51 correlates with delayed mitosis. Indeed, Rad51 foci do not persist in mitotic cells even after G2 checkpoint suppression, suggesting that their disassembly is a prerequisite for chromosome segregation.
We conclude that Rad51 binding by the C-terminal Brca2 motif is dispensable for the execution of HR but instead links the disassembly of Rad51 complexes to mitotic entry. This mechanism may ensure that HR terminates before chromosome segregation. Our findings assign a biological function for the C-terminal Brca2 motif in a mechanism that coordinates DNA repair with the cell cycle.
Rad51重组酶在DNA上组装以执行同源DNA重组(HR)。这一过程对于在细胞进入有丝分裂之前修复与复制相关的基因组损伤至关重要,但在细胞周期中它是如何启动和停止的仍知之甚少。Rad51组装受乳腺癌抑制因子Brca2通过其进化保守的BRC重复序列以及生物学功能尚不确定的独特羧基(C)末端基序调控。通过“打了就跑”基因靶向技术在禽类Brca2基因座中插入单密码子替换,我们在此报告了C末端基序以前未被认识的作用。
我们表明禽类C末端基序与其人类对应物在功能上同源,并鉴定出消除或增强Rad51结合的点突变。当将这些突变引入Brca2时,我们发现它们既不影响Rad51在受损DNA上组装成核灶,也不影响HR介导的DNA修复。相反,在一个无法结合Rad51的点突变体中,灶的解体更快,这与更快进入有丝分裂相关。相反,在一个组成性结合Rad51的点突变体中,灶的解体较慢与有丝分裂延迟相关。事实上,即使在G2期检查点被抑制后,Rad51灶在有丝分裂细胞中也不会持续存在,这表明它们的解体是染色体分离的先决条件。
我们得出结论,C末端Brca2基序对Rad51的结合对于HR的执行是可有可无的,但它将Rad51复合物的解体与有丝分裂进入联系起来。这种机制可能确保HR在染色体分离之前终止。我们的发现为C末端Brca2基序在协调DNA修复与细胞周期的机制中赋予了生物学功能。